Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin Dosing in Normal Weight C-Section
NCT01880112Phase 4Withdrawn
- Sponsor
- West Virginia University
- Start
- Jun 2011
- Primary completion
- Jun 2013
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of cefazolin in surgical site infection (SSI), sponsored by West Virginia University. Planned start Jun 2011; status: withdrawn.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT01880112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01880112.